
Zentek Ltd. — Investor Relations & Filings
Zentek Ltd. is an intellectual property development and commercialization company focused on applying advanced nanotechnology and nanomaterials, specifically graphene, to solve complex challenges in health, safety, and the environment. The company specializes in developing and commercializing next-generation healthcare solutions across prevention, detection, and treatment. Zentek utilizes strategic partnerships to advance its patented nanotechnologies. A key commercialized product is ZenGUARD™, an antimicrobial coating that employs a graphene-silver combination to significantly enhance viral and bacterial filtration performance in applications such as surgical masks and air filters.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-19 | English | |
| Offering document - English.pdf | 2026-05-14 | English | |
| News release - English.pdf | 2026-05-14 | English | |
| Offering document - English.pdf | 2026-05-14 | English | |
| News release - English.pdf | 2026-05-14 | English | |
| Offering document - English.pdf | 2026-05-14 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47796556 | News release - English.pdf | 2026-05-19 | English | ||
| 46243948 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243947 | News release - English.pdf | 2026-05-14 | English | ||
| 46243925 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243922 | News release - English.pdf | 2026-05-14 | English | ||
| 46243888 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243884 | News release - English.pdf | 2026-05-14 | English | ||
| 46243849 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243845 | News release - English.pdf | 2026-05-14 | English | ||
| 46243813 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243810 | News release - English.pdf | 2026-05-14 | English | ||
| 46243781 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243780 | News release - English.pdf | 2026-05-14 | English | ||
| 46243751 | Offering document - English.pdf | 2026-05-14 | English | ||
| 46243750 | News release - English.pdf | 2026-05-14 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Jasper Therapeutics, Inc.
A clinical-stage biotech developing therapies targeting mas…
|
JSPR | US | Professional, scientific and te… |
|
Jeevan Scientific Technology Limited
A CRO providing Phase I-IV trials, BA/BE research, and phar…
|
538837 | IN | Professional, scientific and te… |
|
J. Molner AS
A CDRO developing generic sterile injectable and dermatolog…
|
JML | EE | Professional, scientific and te… |
|
JOINN Laboratories (China) Co., Ltd.
Comprehensive CRO providing end-to-end preclinical drug dis…
|
6127 | HK | Professional, scientific and te… |
|
JOINN LABORATORIES (CHINA) CO., LTD.
A CRO specializing in non-clinical safety assessment and ph…
|
603127 | CN | Professional, scientific and te… |
|
Kadimastem Ltd.
Clinical-stage cell therapy company developing treatments f…
|
KDST | IL | Professional, scientific and te… |
|
KAINOS MEDICINE, INC.
Develops small molecule therapeutics for neurodegenerative,…
|
284620 | KR | Professional, scientific and te… |
|
Kairos Pharma, LTD.
Develops oncology therapies targeting drug resistance and i…
|
KAPA | US | Professional, scientific and te… |
|
Kancera
Pharmaceutical company seeking a reverse takeover to levera…
|
KAN | SE | Professional, scientific and te… |
|
KAZIA THERAPEUTICS LTD
Oncology-focused biotech developing targeted therapies for …
|
KZIA | US | Professional, scientific and te… |
Zentek Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46678/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46678 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46678 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46678 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46678}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zentek Ltd. (id: 46678)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.